[PHARMA] QoQ Cumulative Quarter Result on 30-Sep-2011 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
01-Nov-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
30-Sep-2011 [#3]
Profit Trend
QoQ- 36.77%
YoY- 23.21%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Revenue 903,482 446,745 1,520,981 1,153,195 781,763 385,328 1,378,348 -24.56%
PBT 70,573 42,955 73,186 56,818 41,172 21,792 45,462 34.10%
Tax -25,435 -13,894 -20,401 -16,215 -11,528 -6,193 -15,152 41.29%
NP 45,138 29,061 52,785 40,603 29,644 15,599 30,310 30.43%
-
NP to SH 44,398 28,685 52,157 40,215 29,404 15,484 30,384 28.79%
-
Tax Rate 36.04% 32.35% 27.88% 28.54% 28.00% 28.42% 33.33% -
Total Cost 858,344 417,684 1,468,196 1,112,592 752,119 369,729 1,348,038 -26.00%
-
Net Worth 481,282 474,161 514,273 464,307 451,381 437,661 421,524 9.24%
Dividend
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Div 17,650 8,824 35,304 - - - 10,698 39.66%
Div Payout % 39.76% 30.76% 67.69% - - - 35.21% -
Equity
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Net Worth 481,282 474,161 514,273 464,307 451,381 437,661 421,524 9.24%
NOSH 117,672 117,657 117,682 106,983 106,962 107,007 106,985 6.55%
Ratio Analysis
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
NP Margin 5.00% 6.51% 3.47% 3.52% 3.79% 4.05% 2.20% -
ROE 9.22% 6.05% 10.14% 8.66% 6.51% 3.54% 7.21% -
Per Share
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
RPS 767.79 379.70 1,292.44 1,077.92 730.88 360.09 1,288.35 -29.20%
EPS 37.73 24.38 44.32 37.59 27.49 14.47 28.40 20.87%
DPS 15.00 7.50 30.00 0.00 0.00 0.00 10.00 31.06%
NAPS 4.09 4.03 4.37 4.34 4.22 4.09 3.94 2.52%
Adjusted Per Share Value based on latest NOSH - 106,933
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
RPS 62.69 31.00 105.53 80.01 54.24 26.74 95.64 -24.56%
EPS 3.08 1.99 3.62 2.79 2.04 1.07 2.11 28.70%
DPS 1.22 0.61 2.45 0.00 0.00 0.00 0.74 39.59%
NAPS 0.3339 0.329 0.3568 0.3222 0.3132 0.3037 0.2925 9.23%
Price Multiplier on Financial Quarter End Date
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Date 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 -
Price 10.18 5.90 5.36 5.90 5.90 5.73 5.31 -
P/RPS 1.33 1.55 0.41 0.55 0.81 1.59 0.41 119.29%
P/EPS 26.98 24.20 12.09 15.70 21.46 39.60 18.70 27.71%
EY 3.71 4.13 8.27 6.37 4.66 2.53 5.35 -21.67%
DY 1.47 1.27 5.60 0.00 0.00 0.00 1.88 -15.13%
P/NAPS 2.49 1.46 1.23 1.36 1.40 1.40 1.35 50.45%
Price Multiplier on Announcement Date
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Date 08/08/12 03/05/12 22/02/12 01/11/11 10/08/11 13/05/11 25/02/11 -
Price 8.83 5.90 5.90 5.90 5.90 5.05 5.35 -
P/RPS 1.15 1.55 0.46 0.55 0.81 1.40 0.42 95.83%
P/EPS 23.40 24.20 13.31 15.70 21.46 34.90 18.84 15.56%
EY 4.27 4.13 7.51 6.37 4.66 2.87 5.31 -13.53%
DY 1.70 1.27 5.08 0.00 0.00 0.00 1.87 -6.16%
P/NAPS 2.16 1.46 1.35 1.36 1.40 1.23 1.36 36.16%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment